VRDN
Viridian Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$28.68
+0.27 ▲ +0.95%
🌙 3월 13일 4:20 PM ET (한국 3/14 05:20)
$28.68
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -3.81 | Insider Own | 9.93% | Shs Outstand | 0.10B | Perf Week | 1.2% |
| Market Cap | 2.93B | Forward P/E | - | EPS next Y | 49.01% | Insider Trans | 4.66% | Shs Float | 0.09B | Perf Month | -4.62% |
| Enterprise Value | 2.24B | PEG | - | EPS next Q | -1.04 | Inst Own | 98.81% | Short Float | 8.49% | Perf Quarter | -12.02% |
| Income | -0.32B | P/S | 41.37 | EPS this Y | -15.11% | Inst Trans | 14.93% | Short Ratio | 5.4 | Perf Half Y | 45.95% |
| Sales | 0.07B | P/B | 4.95 | EPS next 5Y | - | ROA | -39.5% | Short Interest | 7.82M | Perf YTD | -7.84% |
| Book/sh | 5.8 | P/C | 3.35 | EPS past 3/5Y | 6.35% 36.07% | ROE | -46.52% | 52W High | -16.36% ($34.29) | Perf Year | 81.4% |
| Cash/sh | 8.56 | P/FCF | - | Sales past 3/5Y | 241.95% 132.18% | ROIC | -41.99% | 52W Low | 189.7% ($9.90) | Perf 3Y | -0.59% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -0.85% | Gross Margin | 98.22% | Volatility(W/M) | 5.68% 5.82% | Perf 5Y | 59.33% |
| Dividend TTM | - | EV/Sales | 31.61 | Sales Y/Y TTM | 23359.93% | Oper. Margin | -512.91% | ATR (14) | 1.62 | Perf 10Y | -77.68% |
| Dividend Ex-Date | - | Quick Ratio | 12.65 | EPS Q/Q | -33.79% | Profit Margin | -457.63% | RSI (14) | 45.33 | Recom | 1.11 |
| Dividend Gr. 3/5Y | - | Current Ratio | 12.65 | Sales Q/Q | 83.33% | SMA20 | -0.57% ($28.84) | Beta | 1.02 | Target Price | $41.5 |
| Payout | - | Debt/Eq | 0.07 | Earnings | 2000000 | SMA50 | -6.03% ($30.52) | Rel Volume | 0.78 | Prev Close | $28.41 |
| Employees | 252 | LT Debt/Eq | 0.07 | EPS/Sales Surpr. | -10.24% -99.28% | SMA200 | 20.94% ($23.71) | Avg Volume(3M) | 1.45M | Price | $28.68 |
| IPO | 2014/6/18 | Option/Short | Yes/Yes | Trades | 13108 | Volume | 1,131,576 | Change | 0.95% |
뉴스 로딩 중...